Abstract
Methotrexate forms an inclusion complex with β-cyclodextrin (β-CyD) by a neutralization method. The formation of the inclusion complex was studied by phase solubility, X-ray diffractometry, differential scanning calorimetry and infrared spectroscopy. The amino group of methotrexate interacted with the hydroxyl function of β-CyD on complexation. The in-vitro drug release from the complex in phosphate buffer, pH-7.2, was better than that of the plain drug and other preparations evaluated. The complex had better bioavailability and showed better antitumour efficacy than methotrexate alone.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 573-577 |
Number of pages | 5 |
Journal | Pharmaceutical Sciences |
Volume | 3 |
Issue number | 12 |
Publication status | Published - 1997 |